Leukemia, an effective model for chemical biology and target therapy.

about

Current advances in the application of proteomics in apoptosis research.Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial.

P2860

Q37854521-9D919B76-E372-46A6-B732-7C7B23BB835D Q38856584-1B1E708A-F96C-4B71-9F03-863D55032A05

P2860

Leukemia, an effective model for chemical biology and target therapy.

Item

http://www.wikidata.org/entity/Q36920748

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Leukemia, an effective model for chemical biology and target therapy.

@en

type

Item

label

Leukemia, an effective model for chemical biology and target therapy.

@en

prefLabel

Leukemia, an effective model for chemical biology and target therapy.

@en

P1476

Leukemia, an effective model for chemical biology and target therapy.

@en

P2093

Guo-qiang Chen

http://www.w3.org/2001/XMLSchema#string

Li-shun Wang

http://www.w3.org/2001/XMLSchema#string

Ying-li Wu

http://www.w3.org/2001/XMLSchema#string

Yun Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Navigating chemical space for biology and medicine

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

Overriding imatinib resistance with a novel ABL kinase inhibitor

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Apoptosis-based therapies for hematologic malignancies.

Transcription factor fusions in acute leukemia: variations on a theme.

The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.

P2888

j.1745-7254.2007.00680.x

P304

1316-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1745-7254.2007.00680.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6117504

http://www.w3.org/2001/XMLSchema#string

P6179

1039411810

http://www.w3.org/2001/XMLSchema#string

P698

17723165

http://www.w3.org/2001/XMLSchema#string

Leukemia, an effective model for chemical biology and target therapy.

about

P2860

P2860

Leukemia, an effective model for chemical biology and target therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698